ArticleBreast cancer research : BCR2011

A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.

Elena Muraro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.